Join
Sign in
Groups
All Groups
JDRF Chapter Groups
Local Support Groups
Local Camp Groups
Resources
People in the Know
Adult Type 1 Toolkit
Educating Others
Find a JDRF Local Chapter
JDRF Calendar
Forums
Welcome to TypeOneNation
General discussions
Diet & Exercise discussions
Daily Living discussions
Pre-Diabetes topics
Peers discussions
Videos
JDRF Videos
Community Videos
Blogs
Advocacy Blog
JDRF News Blog
Friday Five Blog
T1D Tuesday
All Blogs
Home
»
Video
»
JDRF Videos
»
JDRF Videos
»
JDRF Research Strategy, Spring 2010
JDRF Research Strategy, Spring 2010
JDRF Videos
Videos from JDRF on a range of topics
Get this RSS feed
Home
Files
Options
Download file
Share this
View slideshow
Info
Posted by
Gary Feit
When:
4 Mar 2010
Downloads:
561
File Size:
Views:
2,921
Tags
adults with type 1
advocacy
college
Crystal Bowersox
Cure
Diabetes
diabetes research
high school
independence
JDRF
Jeffrey Brewer
Life
life with diabetes
Meg
NDAM
Novo Nordisk
Research
T1Day
teen
teenager
type 1 diabetes
Voices
Walk
Young
Young Voices
JDRF Videos
Subscribe
JDRF Research Strategy, Spring 2010
Gary Feit
Download
Share
JDRF's Chief Scientific Officer, Dr. Richard Insel, discusses JDRF's research strategy.
Posted:
4 Mar 2010
JDRF
,
Research
Downloads:
561
Size:
Views:
2,921
Embed
Tweet
ABOUT TYPEONENATION
TypeOneNation is a vibrant social network created especially for and by people with type 1 diabetes and their loved ones.
More about TypeOneNation
Terms of Service
|
Privacy Policy
DONATION
Please consider making a donation to JDRF to support research toward better treatments and a cure for type 1 diabetes.
SUPPORT
For help on TypeOneNation you can view answers to common support questions or contact us.
JDRF is the worldwide leader for research to prevent, better treat, and ultimately cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.
More about JDRF
TypeOneNation is funded through an educational grant from Novo Nordisk through its Changing Diabetes© leadership initiative.
More about Novo Nordisk